ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$3.14
+0.00 (+0.00%)
Open$3.14
Previous Close$3.14
Day High$3.15
Day Low$3.14
52W High$4.18
52W Low$0.69
Volume—
Avg Volume31.75M
Market Cap808.25M
P/E Ratio—
EPS$-0.17
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+502.2% upside
Current
$3.14
$3.14
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 504.03M | 288.38M | 122.60M |
| Net Income | -28,353,768 | -14,600,292 | 36.77M |
| Profit Margin | -5.6% | -5.4% | 30.0% |
| EBITDA | 75.47M | 41.02M | 61.92M |
| Free Cash Flow | — | — | 30.39M |
| Rev Growth | +74.8% | +74.8% | -8.9% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |